Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism
about
Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte deathRole and Function of MicroRNAs in Extracellular Vesicles in Cardiovascular BiologyMechanosensitive microRNAs-role in endothelial responses to shear stress and redox stateDeveloping miRNA therapeutics for cardiac repair in ischemic heart diseaseNoncoding RNA in age-related cardiovascular diseasesMicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNFαImplication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cellsNotoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse modelThe role of TGF-β1-miR-21-ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells.Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration.Adenosine stimulates the migration of human endothelial progenitor cells. Role of CXCR4 and microRNA-1504-HNE increases intracellular ADMA levels in cultured HUVECs: evidence for miR-21-dependent mechanismsPervasive roles of microRNAs in cardiovascular biology.Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3.Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells.Recombinant adeno-associated virus-mediated inhibition of microRNA-21 protects mice against the lethal schistosome infection by repressing both IL-13 and transforming growth factor beta 1 pathways.Mechanisms of thrombosis in obesity.Clinical significance and expression of microRNA in diabetic patients with erectile dysfunction.Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.Challenges and opportunities for stem cell therapy in patients with chronic kidney diseaseBiological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases.MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms.MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2MicroRNAs as pharmacological targets in endothelial cell function and dysfunctionBone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators.MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway.Functions of microRNAs in cardiovascular biology and disease.Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.MicroRNA-based therapeutic approaches in the cardiovascular system.MicroRNAs as mediators and therapeutic targets in chronic kidney disease.MicroRNAs in hypertension: mechanisms and therapeutic targets.Non-cardiomyocyte microRNAs in heart failure.miRNAs as potential therapeutic targets for age-related macular degeneration.Cardiac myocyte-fibroblast interactions and the coronary vasculature.Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets.Molecular network analysis of human microRNA targetome: from cancers to Alzheimer's diseaseCurrent status of cell-based therapy for heart failure.Oxidative stress and microRNAs in vascular diseases.New paradigms in inflammatory signaling in vascular endothelial cells.
P2860
Q24595733-2D9E9CC0-CCEA-42AE-A395-3AD85387F8F0Q26777595-73B90DA2-39FD-4C80-B538-6873C0DDAA3EQ26851899-7F3F809B-280F-402D-9E79-8DC66A513DFFQ28077986-31FA9684-49B2-4088-9042-B9CE6FEA8016Q28081466-0DF53546-F660-4901-85CA-CD0538744186Q28117223-6B982D3A-FD90-4F77-BB30-C6C87B776FC9Q28392601-12AA8688-3CE1-42E5-8A58-3F912D7DF3D3Q28539734-1043481B-61DA-4F57-BA36-22654681924AQ34051982-3A36A069-02FA-4781-BBA3-B0179E26D231Q34358827-BF8FBA83-B597-4CA6-8881-EA928C45A9B4Q34552184-4BA79D05-9258-459E-A483-54CBCFEB6997Q34745328-6415E1CF-AC04-41AC-9223-A788F50F4CACQ34775686-5D8BA96E-6E01-476F-9E8E-E6AEEFEF1927Q34849698-7DACBE18-96C8-4AB8-926B-D06C055360D3Q35625384-A5C072E3-0BFA-46A9-8ADB-0BEB58C75B9FQ35637946-81A27C2D-C014-4C21-9171-46D7CF83922EQ35653311-F13DACE3-F0CD-4918-96B3-18586412A9D4Q35802924-809E589D-E423-43B9-8320-1D6966A20B93Q36194321-0D01DA9E-2F56-451D-9F6F-A44621A54EF9Q36481807-87E5E0DB-7558-452E-989B-E026229C8B06Q36711673-C3B1CFE9-895D-4A20-82EC-2CDE50814061Q36817578-E25169A2-3368-455E-99E6-7A88F057CDAAQ36890424-F7E3D209-A1DE-41C5-9509-284C17FB07A2Q37034383-0A4BA195-3CE2-43CF-B620-0D20160E3E30Q37118124-F0674E78-46AE-468C-847C-6B3890E5D044Q37294594-1330785A-F785-440A-A160-9650BFC7DA67Q37419073-537ED19F-5A0E-4546-8DFF-AA648B32EFC8Q37561996-16616C05-F44B-40E5-87E6-09D9E3639A35Q37780204-6893D0E4-3E4F-45B7-8FA2-91F2EA1260F4Q37800144-FB53C89E-19B8-4254-8C53-2E7F1A7E8592Q37855524-86956DBA-1944-444C-AA2D-1F075E1AFC67Q37952576-77B88E2B-BF5A-4D0F-961E-0E32CF0D6022Q37969738-6F956BE2-0304-44E4-B30C-754D91A0DBB0Q37990945-15423E20-6E3E-426A-9FF4-16EA62A34D60Q38044304-D17A54BD-563D-40C2-AA03-49B555995AADQ38044999-6B5B87F8-3914-4FC7-A28C-CDD1757C4E4AQ38049204-1D8223E3-28C0-4DE1-A013-74AD01D0CCDBQ38090542-FDF4CF22-19AB-43C7-97A7-94F703BAF8E2Q38131402-D93D6718-9ABA-4CCC-9ED6-5CE23BF39683Q38166953-0BF21D5D-2917-4A8F-808B-BFB823D5AF13
P2860
Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism
description
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2010
@ast
im Juli 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2010/07/09)
@nl
наукова стаття, опублікована в липні 2010
@uk
مقالة علمية (نشرت في 9-7-2010)
@ar
name
Short communication: asymmetri ...... icroRNA-21-dependent mechanism
@ast
Short communication: asymmetri ...... icroRNA-21-dependent mechanism
@en
type
label
Short communication: asymmetri ...... icroRNA-21-dependent mechanism
@ast
Short communication: asymmetri ...... icroRNA-21-dependent mechanism
@en
prefLabel
Short communication: asymmetri ...... icroRNA-21-dependent mechanism
@ast
Short communication: asymmetri ...... icroRNA-21-dependent mechanism
@en
P2093
P50
P1433
P1476
Short communication: asymmetri ...... icroRNA-21-dependent mechanism
@en
P2093
Felix Fleissner
Georg Ertl
Jan Fiedler
Johann Bauersachs
Paolo Galuppo
Shashi K. Gupta
Susanne Kneitz
Virginija Jazbutyte
P304
P356
10.1161/CIRCRESAHA.110.216770
P577
2010-07-09T00:00:00Z